Arcadia Biosciences Aktie

View in Terminal

Loading quotes...

Forecast

The analysts' average price target is €5.35 (+3,721.43%). The median is €5.35 (+3,721.43%).

Buy	4
Hold	1
Sell	0

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Arcadia Biosciences Aktie had revenue of €1.26m and net profit of -€5.49m

(EUR)	June 2026	YoY
Revenue	1.26m	2.42%
Gross profit	552.89k	3.28%
Net profit	-5.49m	45.16%
EBITDA	-5.49m	45.65%

Fundamentals

Metric	Value
Market capitalization	€222.83k
Number of shares	1.55m
52-week high/low	€3.73 - €0.0989
Dividends	No
Beta	0.55
P/E ratio	-0.02
PEG ratio	0.00
P/B ratio	0.35
P/S ratio	0.05

Company profile

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.